Biochemical association between essential trace elements and susceptibility to Leishmania major in BALB/c and C57BL/6 mice

Brazilian Journal of Infectious Diseases

Volumn 13, Issue 2, 2009, Pages 83-85

  Amini, Marzyeh ^a   Nahrevanian, Hossein ^b   Khatami, Shohreh ^b   Farahmand, Mahin ^b   Mirkhani, Fatemeh ^b   Javadian, Seifoddin ^c  

^a PAYAME NOOR UNIVERSITY   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c NONE

Author keywords

Balb c; C57bl 6; CL; Cu; Iran; Leishmania major; Treatment; Zn

Indexed keywords

BIOLOGICAL MARKER; COPPER; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; COPPER BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; IMMUNE RESPONSE; INFECTION RESISTANCE; INFECTION SENSITIVITY; IRAN; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

ANIMALS; COPPER; FEMALE; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; ZINC;

EID: 76649108269     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702009000200002     Document Type: Article

References (26)

1. Sypek J.P., Chung C.L., Mayor S.E.H., et al. Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response. J Exp Med 1993;177:1797-1802.
2. nd ed. Academic Press, London, United Kingdom; 1987.
3. Reiner S.L., Locksley R.M. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995;13:151-77.
4. Desjeux P., Mollinedo S., Le Pont F., et al. Cutaneous leishmaniasis in Bolivia. A study of 185 human cases from AltoBeni (LaPaz Department). Isolation and isoenzyme characterization of 26 strains of Leishmania braziliensis braziliensis. Trans R Soc Trop Med Hyg 1987;81:742-6.
5. Desjeux P. Leishmaniasis. Public health aspects and control. Clin Dermato 1996;14:417-23.
6. Greenblatt C.L. The present and future of vaccination for cutaneous leishmaniasis. Prog Clin Biol Res 1980;47:259-85.
7. Baldwin T.M., Elso C., Curtis J., et al. The Site of Leishmania major infection determines disease severity and immune responses. Infect Immun 2003;71(12):6830-4.
8. Sacks D., Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002;2:845-58.
9. Matthews D.J., Emson C.L., McKenzie G.J., et al. IL-13 is a susceptibility factor for Leishmania major infection. J Immunol 2000;164:1458-62.
10. Laskay T., Diefenbach M., Rollinghof M., et al. Early parasite containment is decisive for resistance to Leishmania major infection. Eur J Immunol 1995;25:2220-7.
11. Scuderi P. Differential effects of copper and zinc on human peripheral blood cytokine secretion. Cell Immunol 1990;126:391-405.
12. Mastousek A.J., Burguera J.L., Burguera M., et al. Changes in total content of iron, copper and zinc in serum, heart, liver, spleen and skeletal muscle tissues of rats infected with Trypanosome cruzi. Biol Trace Element Res 1993;37:51-69.
13. Cousins R.J. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev 1985;65(2):238-309.
14. Chvapril L.M. New aspects in biological role of zinc: A stabilization of macromolecules and biological membranes. Life Sci 1973;13:1041-9.
15. Sprietsma J.E. Zinc-controlled Th1/Th2 switch significantly determines development of diseases. Med Hypotheses 1997;49(1):1-14.
16. Kocyigit A., Erel Ö., Seyrek A., et al. Effects of antimonial therapy on serum zinc, copper and iron concentrations in patients with cutaneous leishmaniasis. East J Medicin 1998;3(2):58-61.
17. Panemangalore M., Bebe F.N. Effect of high dietary zinc of plasma ceruloplasmin and erythrocyte superoxide dismutase activities in copper-depleted and repleted rats. Biol Trace Elem Res 1996;55(1-2):111-26.
18. Nahrevanian H., Farahmand M., Aghighi Z., et al. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: An Iranian strain of cutaneous leishmaniasis. Exp Parasitol 2007;116:191- 8.
19. Farahmand M., Nahrevanian H., Assmar M., et al. Expression of A2 proteins in amastigotes of Leishmania infantum produced from canine isolates collected in the district of Meshkinshahr, in North-Western Iran. An Trop Med Parasitol 2008;102(1):81-4.
20. Nourmohammadi I., Nazem N., Ehsani-Zenuz A., et al. Serum levels of Zn, Cu, Cr and Ni in Iranian subjects with atherosclerosis. Arch Irn Med 2001;4(1):21-4.
21. Powanda M.C., Beisel W.R. Hypothesis: Leukocyte endogenous mediator/endogenous pyrogen/lymphocyte-activating factor modulates the development of nonspecific and specific immunity and affects nutritional status. Am J Clin Nutr 1982;35:23-9.
22. Briggs W.A., Pedersen M.M., Mahagan S.K., et al. Lymphocyte and granulocyte function in zinc-treated and zinc - deficient hemodialysis patients. Kidney Int 1982;21:827-32.
23. Warner C.L., Lawrence D.A. The effect of metals on IL-2 related lymphocyte proliferation. Int J Immunopharmacol 1988;10:629-37.
24. Rofe A.M., Philcox J.C., Coyle P. Trace metal, acute phase and metabolic response to endotoxin in metallothionein-null mice. Biochem J 1996;314:793-7.
25. Sharifi I., Fekri A.R., Aflatonian M.R., et al. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet 1998;351:1540-3.
26. Khalil E.A., El Hassan A.M., Zijlstra E.E., et al. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. Lancet 2000;356:1565-9.